Labcorp LH
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Labcorp (LH) Core Market Data and Business Metrics
Latest Closing Price
$232.65Price-Earnings Ratio
26.32Total Outstanding Shares
83.70 Million SharesDividend
$0.72 Per Share QuarterlySIC Description
Services-medical LaboratoriesPrimary Exchange
New York Stock ExchangeHeadquarters
358 S Main St, Burlington, NC, 27215
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 820,091 Shares | 2.32 | 3/14/2025 | 1,901,346 Shares |
| 486,475 Shares | 3.8 | 2/28/2025 | 1,850,610 Shares |
| 680,399 Shares | 2.69 | 2/14/2025 | 1,831,926 Shares |
| 572,810 Shares | 3.32 | 1/31/2025 | 1,902,677 Shares |
| 570,442 Shares | 3.53 | 1/15/2025 | 2,014,329 Shares |
| 471,732 Shares | 4.07 | 12/31/2024 | 1,921,215 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow, Continuing | $998.90 Million |
| Net Cash Flow From Investing Activities | $-1.37 Billion |
| Exchange Gains/Losses | $-17 Million |
| Net Cash Flow From Financing Activities | $779.90 Million |
| Net Cash Flow From Operating Activities | $1.59 Billion |
| Net Cash Flow From Financing Activities, Continuing | $779.90 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Revenues | $13.01 Billion |
| Income/Loss From Equity Method Investments | $-1.40 Million |
| Income/Loss From Discontinued Operations Net Of Tax | $0 |
| Income Tax Expense/Benefit, Deferred | $-20.10 Million |
| Common Stock Dividends | $2.88 |
| Income/Loss Before Equity Method Investments | $13.01 Billion |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $1.10 Million |
| Comprehensive Income/Loss | $544.80 Million |
| Other Comprehensive Income/Loss | $-202.30 Million |
| Comprehensive Income/Loss Attributable To Parent | $543.70 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Prepaid Expenses | $697.60 Million |
| Inventory | $493.20 Million |
| Assets | $18.38 Billion |
| Current Liabilities | $3.33 Billion |
| Intangible Assets | $3.49 Billion |
| Wages | $495.40 Million |
Historical Dividends
Current dividend: $0.72 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Jan 8, 2025 | Mar 12, 2025 | Feb 27, 2025 | $0.72 | Quarterly |
| Oct 10, 2024 | Dec 13, 2024 | Nov 26, 2024 | $0.72 | Quarterly |
| Jul 25, 2024 | Sep 13, 2024 | Aug 29, 2024 | $0.72 | Quarterly |
| Apr 11, 2024 | Jun 12, 2024 | May 28, 2024 | $0.72 | Quarterly |
| Jan 12, 2024 | Mar 13, 2024 | Feb 27, 2024 | $0.72 | Quarterly |
| Oct 12, 2023 | Dec 12, 2023 | Nov 8, 2023 | $0.72 | Quarterly |